(3S)-rel-3-[[(2R)-2-cyclopentyl-2-hydroxy-2-phenylacetyl]oxy]-1,1-dimethyl-,Pyrrolidinium bromide (1:1) 98%
Price | Get Latest Price | |||
Packge | 1kg | 5kg | 10kg | 25125kg and 1 MT |
- Min. Order:1kg
- Time:2024-03-15
Product Details
- Product Name(3S)-rel-3-[[(2R)-2-cyclopentyl-2-hydroxy-2-phenylacetyl]oxy]-1,1-dimethyl-,Pyrrolidinium bromide (1:1)
- CAS No.51186-83-5
- EINECS No.209-887-0
- MFC19H28NO3.Br
- MW0
- Melting point 175℃
Company Profile Introduction
Equilife Laboratories Pvt.Ltd.is pharmaceutical company with corporate origins in India.We provide innovative process development of pharmaceutical products and services to clients all over the world.
Equilife Laboratories Private Limited team is Post-graduates in organic chemistry and Microbiology and have rich work experience with more than 19+ years in Research & development and manufacturing of various API at bulk scale. Our team is worked with pharmaceutical companies like Lupin Limited, Actavis pharma Pvt.Ltd, Unichem Impurities and Research institutes/organizations like National chemical laboratory (NCL-Pune), Indian Institute of Technology (IIT-Mumbai). On our record we have more than 10 patents and publication. We are experienced in optimization,scale up on various drug intermediates and drug substances like Anti-cancer (Oncology products), Anti-HIV, Anti-bacterial, Antibiotics, Anti-hepatitis, Anti-hypertensive, Anti-inflammatory, Anti-parkinson’s, Anti-progesterone (oral contraceptives), Anti-depressant, Antipsychotic, Anti-viral, Anti-rheumatic and Diuretics.
Supplier other products
Recommended supplier
-
VIP1年
- Vamsi Labs Ltd
- 51186-83-5 98%
- Inquiry
- 2024-01-05
-
VIP1年
- Alkaloids Private Limited
- 51186-83-5 Glycopyrronium Bromide / Glycopyrrolate 98%
- Inquiry
- 2023-12-19
-
VIP1年
- Laurus Labs Ltd
- 124605-42-1 Methyl(2R,3S)-3-(tert-butoxycarbonylamino)-2-hydroxy-3-phenylpropionate 98%
- Inquiry
- 2024-02-02
- Since:2021-03-01
- Address: 104A, Nea Pure Homes Society, Behind TUVNORD Pvt.Ltd, Baner Annexe, Pune, Maharashtra-411021, India.